Skip to main content
Smart Investors Daily
MetLife, Inc. logo

NYSE · MET

MetLife, Inc.

Financial Services · Insurance - Life

$98.47

Up+$2.69 (+2.81%)

Updated Oct 9, 2026, 9:58 AM

SID Score

8.0/10

Composite research score

Smart Money

62/100

Neutral

Market cap
54.19B
P/E ratio
14.23
Dividend yield
2.30%
52-week range
$67.33 – $100.93
Volume
3.02M
Avg. volume
3.53M

Price performance · MET

MET price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 8, 2026

MET closed at $98.47 after 21 trading sessions, up 1.75% for the selected period.

Last close
$98.47
Period change
+1.75%
Period low
$94.16
Period high
$98.47
Daily close
View OHLC price history
MET OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 8, 2026$95.82$98.75$95.705$98.473.02M
Oct 7, 2026$96.34$96.82$95.42$95.783.18M
Oct 6, 2026$97.19$99.06$97.00$97.164.3M
Oct 5, 2026$94.84$97.39$94.655$96.884.42M
Oct 2, 2026$93.98$94.97$93.98$94.432.98M
Oct 1, 2026$93.71$94.50$92.21$94.353.69M
Sep 30, 2026$94.84$95.56$94.12$94.163.01M
Sep 29, 2026$95.68$96.325$94.42$95.202.62M
Sep 28, 2026$97.51$97.94$95.39$95.823.24M
Sep 25, 2026$97.54$98.45$96.67$97.703.63M
Sep 24, 2026$97.73$98.18$97.06$97.253.44M
Sep 23, 2026$95.20$97.67$95.01$97.202.94M
Sep 22, 2026$97.47$98.00$95.0259$95.922.64M
Sep 21, 2026$97.44$97.8413$96.54$96.641.93M
Sep 18, 2026$96.89$97.29$96.2361$97.047.31M
Sep 17, 2026$97.94$98.37$96.80$97.352.76M
Sep 16, 2026$97.98$98.31$95.39$97.233.5M
Sep 15, 2026$97.41$98.54$96.9201$98.222.07M
Sep 14, 2026$97.52$97.79$96.56$97.753.03M
Sep 11, 2026$98.00$98.25$96.225$97.142.64M
Sep 10, 2026$96.17$96.91$96.015$96.782.23M

Latest MET news

The latest Smart Investors Daily articles mentioning MET.

MET research

Overview

Company profile and research snapshot.

Company profile

MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$93.50
Implied upside
—
Analysts
12
MET recent ratings
DateFirmRatingTarget
Oct 7, 2026BarclaysOverweight—
Oct 7, 2026MizuhoOutperform—
Oct 6, 2026UBSBuy—
Oct 5, 2026TD CowenBuy—
Sep 22, 2026Piper SandlerOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.